Author: lisette.muery

News

Artbio raises 90m USD

Artbio, which is based in Cambridge, Massachusetts, and maintains a presence in Basel (Switzerland), has raised a total of 90 million US dollars as part of an oversubscribed and upsized Series A financing round, further details of which can be found in a press release. Artbio is developing a new class of alpha radioligand therapies (ART). […]

December 13, 2023
News

Merck pharmaceuticals (MSD) inaugurates new research lab capacities in Lucerne, Switzerland

US-based biopharma giant expands its R&D site in Schachen 2023 June 21 – Merck & Co. ($59.3B revenue), a global research-intensive biopharmaceutical company headquartered in New Jersey, has newly expanded its research laboratories in Schachen (located in Canton Lucerne) to the tune of close to 20 Million Swissfrancs. Known as Merck Sharpe & Dohme or […]

July 13, 2023
News

IDUN receives EU funding for sleep improvement platform

Opfikon – The neurotech start-up IDUN Technologies has received Eurostars funding together with its project partners Cerebra Medical Ltd. and Pilotfish Nederland BV. This grant will be put towards the development of a personalized sleep improvement platform. The start-up IDUN Technologies from Opfikon in the canton of Zurich has received funding from the Eurostars program for its joint project […]

April 28, 2023
News

Life Sciences CC Association founded in Ticino

Bellinzona – The Life Sciences CC Association has officially been established. It will lead the competence center for life sciences research at the future Switzerland Innovation Park Ticino. Its specific focus will be on bio-fabrication in connection with drug development. Switzerland Innovation Park Ticino has taken a major step forward in its development with the founding […]

April 28, 2023
News

Earpiece could make post-stroke surgery a thing of the past

Zurich – Two scientists from the Swiss Federal Institute of Technology in Zurich have developed an earpiece to help speed up the recovery from a stroke. The technology stimulates the brain and could prevent the need for surgery. The solution is set to be launched on the market by a dedicated spin-off. Two researchers from […]

April 28, 2023
Success Stories

Apellis in the Greater Zurich Area

Apellis Pharmaceuticals is an American biotech company that has established a hub in the Greater Zurich Area for all its non-US activities since the beginning of 2019. Apellis currently has more than 750 employees, including those at its headquarters in Waltham, Massachusetts. Over 30 highly experienced pharma experts are employed by Apellis Switzerland GmbH in […]

April 28, 2023
News

UZH Tumor Profiler advances personalized cancer treatments

Zurich – The Tumor Profiler project of the University of Zurich (UZH) allows tumor cells to be analyzed with a degree of precision never seen before. This individual tumor profiling has already helped a third of the cancer patients in a study, causing their tumors to shrink. The University of Zurich (UZH) has announced the […]

April 28, 2023
News

Greater Zurich Area – The Hotspot for Life Sciences in Europe’s Most Innovative Environment

In recent years, the Greater Zurich Area (GZA) has established itself as a leading center for life sciences in Europe. Major international companies are based here, attracting investors and professionals from all over the world. So, what sets Greater Zurich apart and what makes the region so attractive to companies in the healthcare industry?  Switzerland […]

April 28, 2023
News

Lucerne University and Swiss Medtech company partner on surgical instruments

Market maturity is expected within two years’ time 2023 March 27 – Researchers from the Lucerne-based university, the Lucerne University of Applied Sciences and Arts (HSLU) are working together with the Swiss company Oertli Instrumente to develop improved instruments for cataract operations.  The aim of the collaboration is to increase the efficiency of cataract operations […]

April 17, 2023